While WHO’s recent Executive Board meeting saw a considerable amount of sound and fury over the proposed pandemic treaty, an obscurely titled but vital appendix of updated “best buys” to combat noncommunicable diseases (NCDs) was also briefly on stage.  This new set of cost-effective recipes to combat what are now the world’s biggest killers provides […] Continue reading ->
Higher taxes and warning labels on unhealthy food, cigarettes and alcohol, and better screening for cancers, are on the World Health Organization’s (WHO) updated list of “best buys” to address non-communicable diseases (NCD) discussed by member states at the body’s Executive Board meeting on Thursday. The list was updated in response to the lack of […] Continue reading ->
The number of people requiring treatment for Neglected Tropical Diseases (NTDs) decreased from 2.19 to 1.65 billion between 2010 and 2021 – an impressive 25 percent decline. However, interlinked challenges, including the COVID pandemic and, now, accelerating patterns of climate change are putting this progress at risk.  On World NTD Day, we need to recognise […] Continue reading ->
DAVOS, Switzerland  – The World Health Organization (WHO) has announced plans to set up a new TB Vaccine Accelerator Council to increase momentum for the development of a vaccine to combat the world’s most deadly infectious disease. Speaking at a high-level panel at the World Economic Forum’s Annual Meeting where the plan was launched, WHO […] Continue reading ->
On the occasion of Universal Health Coverage Day, thought leaders on the front lines outline the challenges and opportunities of health systems in conflicts. The last decade of 12-year-old Zaynab’s life has been spent in an informal settlement in Lebanon, after her family fled from the Syrian conflict. She shares a three-room tent with her […] Continue reading ->
Keep the momentum to negotiate a pandemic instrument, urged Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO) at the start of the third meeting of the intergovernmental negotiating body (INB) on Monday. “The conceptual zero-draft that your bureau has developed is a true reflection of the aspirations for a different paradigm for […] Continue reading ->
A candidate drug for people with early Alzheimer’s disease slowed cognitive decline by about 27% over 18 months, according to a report on a phase 3 trial published in the New England Journal of Medicine on Tuesday. Lecanemab is a monoclonal antibody that is given as an intravenous infusion every two weeks, and targets a […] Continue reading ->